iRhythm Holdings, Inc.

IRTC · XNAS

CIK 1388658fmd_1J2MZFMNT98T99BRPY2AYE9YSNManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2014 to Sep 30, 2026, 48 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	64	99	147	215	265	323	411	493	592	747
Cost of revenue	21	28	39	52	70	109	129	161	184	220
Gross profit	43	71	108	162	195	214	282	332	408	527
Research and development	7	13	21	37	41	39	47	60	71	85
Selling, general and administrative	52	85	133	180	197	275	322	386	419	493
Total operating expenses	59	99	154	217	239	314	395	457	523	585
Operating income	(16)	(28)	(46)	(55)	(44)	(100)	(114)	(125)	(116)	(57)
Interest expense	3	3	3	2	2	1	4	4	13	13
Interest and investment income	–	–	–	–	–	–	2	6	22	22
Other non-operating income (expense)	(2)	1	2	2	2	0	(2)	3	3	14
Income before taxes	(21)	(30)	(50)	(55)	(44)	(101)	(116)	(123)	(113)	(44)
Income tax expense	0	0	0	0	0	0	0	1	1	1
Net income from continuing operations	(21)	(30)	(50)	(55)	(44)	(101)	(116)	(123)	(113)	(45)
Net income	(21)	(30)	(50)	(55)	(44)	(101)	(116)	(123)	(113)	(45)